Search
for
Sort by
Research 661–690 of 1000+
- Formulation and evaluation of polyherbal hair gel formulation
- Dermatological drugs, topical agents, and cosmetics
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Alopecia Areata
- Is dehydroepiandrosterone a hormone?
- Treatment of Hair Loss
- The Dynamics of the Skin’s Immune System
- Mucocutaneous reactions to chemotherapy
- Selective follicular targeting by modification of the particle sizes
- Evaluation and treatment of male and female pattern hair loss
- Lupus erythematosus: systemic and cutaneous manifestations
- Human Scalp Hair Follicles Are Both a Target and a Source of Prolactin, which Serves as an Autocrine and/or Paracrine Promoter of Apoptosis-Driven Hair Follicle Regression
- HAIR REGROWTH
- Medical and surgical therapies for alopecias in black women
- Androgens and androgen receptor action in skin and hair follicles
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Antioxidants in dermatology
- Alopecia Areata Update
- Central hair loss in African American women: Incidence and potential risk factors
- CHRONIC TELOGEN EFFLUVIUM
- The role of nuclear hormone receptors in cutaneous wound repair
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Development and Evaluation of a Novel Delivery System Containing Phytophospholipid Complex for Skin Aging
- Relative uptake of minoxidil into appendages and stratum corneum and permeation through human skin in vitro
- Hair and scalp disorders in ethnic populations
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus